Suppression of hepatic stellate cell activation by microRNA-29b

Biochemical and Biophysical Research Communications

Volumn 412, Issue 1, 2011, Pages 74-79

  Sekiya, Yumiko ^a   Ogawa, Tomohiro ^a   Yoshizato, Katsutoshi ^a,b   Ikeda, Kazuo ^c   Kawada, Norifumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PhoenixBio USA Corporation   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Smooth muscle actin; Akt; C fos; Extracellular signal regulated kinase; Focal adhesion kinase; Liver fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA1 INTEGRIN; COLLAGEN; COLLAGEN ALPHA1 CHAIN; COLLAGEN ALPHA2 CHAIN; DISCOIDIN DOMAIN RECEPTOR 2 PROTEIN; FIBRONECTIN; FOCAL ADHESION KINASE; MICRORNA; MICRORNA 29B; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDES AND PROTEINS; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STELLATE CELL;

ACTINS; ANIMALS; ANTIGENS, CD29; COLLAGEN TYPE I; FIBRONECTINS; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, MITOGEN; RNA, MESSENGER;

EID: 80051784270     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.041     Document Type: Article

References (26)

1. Bataller R., Brenner D.A. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 2001, 21:437-451.
2. Friedman S.L. Molecular regulation of hepatic fibrosis an integrated cellular response to tissue injury. J. Biol. Chem. 2000, 275:2247-2250.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Guo C.J., Pan Q., Jiang B., Chen G.Y., Li D.G. Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis 2009, 14:1331-1340.
5. Guo C.J., Pan Q., Li D.G., Sun H., Liu B.W. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J. Hepatol. 2009, 50:766-778.
6. Ji J.L., Zhang J.S., Huang G.C., Qian J., Wang X.Q., Mei S. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett. 2009, 583:759-766.
7. Venugopal S.K., Jiang J., Kim T.H., Li Y., Wang S.S., Torok N.J., Wu J., Zern M.A. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G101-G106.
8. Y. Sekiya, T. Ogawa, M. Iizuka, K. Yoshizato, K. Ikeda, N. Kawada, Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation, J. Cell. Physiol. 2010, doi:. doi:10.1002/jcp22598.
9. Ogawa T., Iizuka M., Sekiya Y., Yoshizato K., Ikeda K., Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem. Biophys. Res. Commun. 2010, 391:316-321.
10. Roderburg C., Urban G.W., Bettermann K., Vucur M., Zimmermann H., Schmidt S., Janssen J., Koppe C., Knolle P., Castoldi M., Tacke F., Trautwein C., Luedde T. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:209-218.
11. Uyama N., Zhao L., Van Rossen E., Hirako Y., Reynaert H., Adams D.H., Xue Z., Li Z., Robson R., Pekny M., Geerts A. Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions. Gut 2006, 55:1276-1289.
12. Xu L., Hui A.Y., Albanis E., Arthur M.J., O'Byrne S.M., Blaner W.S., Mukherjee P., Friedman S.L., Eng F.J. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005, 54:142-151.
13. Bissell D.M., Roulot D., George J. Transforming growth factor beta and the liver. Hepatology 2001, 34:859-867.
14. Marra F., Pinzani M., Defranco R., Laffi G., Gentilini P. Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. FEBS Lett. 1995, 376:141-145.
15. Olaso E., Ikeda K., Eng F.J., Xu L.M., Wang L.H., Lin H.C., Friedman S.L. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J. Clin. Invest. 2001, 108:1369-1378.
16. Olaso E., Labrador J.P., Wang L.H., Ikeda K., Eng F.J., Klein R., Lovett D.H., Lin H.C., Friedman S.L. Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J. Biol. Chem. 2002, 277:3606-3613.
17. Marra F., Pastacaldi S., Romanelli R.G., Pinzani M., Ticali P., Carloni V., Laffi G., Gentilini P. Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. FEBS Lett. 1997, 414:221-225.
18. Wang D.R., Sato M., Li L.N., Miura M., Kojima N., Senoo H. Stimulation of pro-MMP-2 production and activation by native form of extracellular type I collagen in cultured hepatic stellate cells. Cell Struct. Funct. 2003, 28:505-513.
19. Borkham-Kamphorst E., Herrmann J., Stoll D., Treptau J., Gressner A.M., Weiskirchen R. Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab. Invest. 2004, 84:766-777.
20. Lechuga C.G., Hernandez-Nazara Z.H., Hernandez E., Bustamante M., Desierto G., Cotty A., Dharker N., Choe M., Rojkind M. PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC, Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G1051-G1061.
21. Carloni V., Romanelli R.G., Pinzani M., Laffi G., Gentilini P. Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 1997, 112:522-531.
22. Rodriguez-Juan C., de la Torre P., Garcia-Ruiz I., Diaz-Sanjuan T., Munoz-Yague T., Gomez-Izquierdo E., Solis-Munoz P., Solis-Herruzo J.A. Fibronectin increases survival of rat hepatic stellate cells - a novel profibrogenic mechanism of fibronectin. Cell. Physiol. Biochem. 2009, 24:271-282.
23. Wu H.J., Zhang Z.Q., Yu B., Liu S., Qin K.R., Zhu L.A. Pressure activates Src-dependent FAK-Akt and ERK1/2 signaling pathways in rat hepatic stellate cells. Cell. Physiol. Biochem. 2010, 26:273-280.
24. Ikeda K., Wang L.H., Torres R., Zhao H., Olaso E., Eng F.J., Labrador P., Klein R., Lovett D., Yancopoulos G.D., Friedman S.L., Lin H.C. Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen. J. Biol. Chem. 2002, 277:19206-19212.
25. Gao R., Ball D.K., Perbal B., Brigstock D.R. Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J. Hepatol. 2004, 40:431-438.
26. Poulos J.E., Weber J.D., Bellezzo J.M., Bisceglie A.M.D., Britton R.S., Bacon B.R., Baldassare J.J. Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. Am. J. Physiol. 1997, 273:G804-G811.